Patent · US Active

Method for solid phase synthesis of liraglutide

US9260474B2 · kind B2 · utility

5Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2012
Grant dateFeb 16, 2016
Priority date
Expiry dateSep 28, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided is a method for solid phase synthesis of liraglutide, comprising the following steps: A), Fmoc-Gly-resin being obtained by coupling resin solid phase carrier with glycine with N-end protected by Fmoc(Fmoc-Gly-OH) in the presence of activator system; B) according to the peptide sequence of the main chain of liraglutide, successively coupling with amino acids with N-ends protected by Fmoc and protected side chains by the method for solid phase synthesis, wherein lysine employs Fmoc-Lys(Alloc)-OH; C) removing the protective group, Alloc, from the side chain of lysine; D) coupling the side chain of lysine with Palmitoyl-Glu-OtBu by the method for solid phase synthesis; E) cleavage, removing protection groups and resin to obtain crude liraglutide; F) purifying and lyophilizing to obtain liraglutide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.